Occidental Petroleum
OXY
Moody's
MCO
Apple
AAPL
Citigroup
C
Chevron
CVX
US Stock MarketDetailed Quotes
ABIO ARCA biopharma
- 2.400
- 0.0000.00%
Close Aug 30 16:00 ET
89.86MMarket Cap-4.90P/E (TTM)
0.000High0.000Low0Volume0.000Open2.400Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)37.44MShares33.00052wk High0.24P/B11.49MFloat Cap10.90852wk Low--Dividend TTM4.79MShs Float40837854.871Historical High--Div YieldTTM0.00%Amplitude10.068Historical Low--Avg Price1Lot Size
ARCA biopharma News
10-K: Annual report
10-Q: Q3 2024 Earnings Report
FMR LLC Acquires New Stake in ARCA Biopharma Inc
Oruka Therapeutics Completes Merger With ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Express News | Oruka Therapeutics Announces Closing of Merger With ARCA Biopharma and Previously Announced Private Placement of $275 Million
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
ARCA Biopharma To Carry Out 1-for-12 Reverse Stock Split On September 3rd, 2024
August 29th (Eastern Time) - $ARCA biopharma(ABIO.US)$ is about to implement a 1-for-12 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 3rd, 2024
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
ARCA Biopharma To Go Ex-Dividend On August 29th, 2024 With 1.613 USD Special Dividend Per Share
August 27th (Eastern Time) - $ARCA biopharma(ABIO.US)$ is trading ex-dividend on August 29th, 2024.Shareholders of record on August 26th, 2024 will receive 1.613 USD special dividend per share on
Reported Earlier, ARCA Biopharma Updates Special Dividend To $1.613/Share In Preparation For Oruka Therapeutics Merger
Press Release: ARCA Biopharma Provides Update Regarding Special Dividend Amount in Connection With the Proposed Merger With Oruka Therapeutics
ARCA Biopharma Provides Update Regarding Special Dividend Amount In Connection With The Proposed Merger With Oruka Therapeutics >ABIO
ARCA Biopharma Declares $1.59 Special Dividend
ARCA Biopharma to Implement 1-For-12 Reverse Stock Split
ARCA Biopharma Announces 1-For-12 Reverse Stock Split In Connection With The Proposed Merger With Oruka Therapeutics; To Begin Trading On A Post-reverse Stock Split Basis On The Nasdaq Global Market On September 3, 2024, And Under The New Symbol "ORKA"
ARCA Biopharma Announces 1-for-12 Reverse Stock Split in Connection With the Proposed Merger With Oruka Therapeutics
Stocks Ex-Dividend August 26
We're Not Very Worried About ARCA Biopharma's (NASDAQ:ABIO) Cash Burn Rate
Top Midday Gainers
Why ARCA Biopharma Shares Are Trading Higher Today
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.